{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:00:13Z","timestamp":1790118013908,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"39","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,10,14]]},"DOI":"10.1038\/s41388-026-03943-1","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:28:15Z","timestamp":1786123695000},"page":"4149-4164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FGD5 regulates PGK1 ubiquitination to synergize with 2-deoxy-D-glucose in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"45","author":[{"given":"Wenting","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-5954","authenticated-orcid":false,"given":"Kun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7663-629X","authenticated-orcid":false,"given":"Shiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suye","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1785-5147","authenticated-orcid":false,"given":"Chengyi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"3943_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3943_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326:851\u201362.","journal-title":"JAMA"},{"key":"3943_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"3943_CR4","doi-asserted-by":"publisher","first-page":"16022.","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers"},{"key":"3943_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","volume":"77","author":"J Yang","year":"2020","unstructured":"Yang J, Ren B, Yang G, Wang H, Chen G, You L, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020;77:305\u201321.","journal-title":"Cell Mol Life Sci"},{"key":"3943_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z. Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis. 2024;15:553.","journal-title":"Cell Death Dis"},{"key":"3943_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.molmed.2024.03.008","volume":"30","author":"MC De Santis","year":"2024","unstructured":"De Santis MC, Bockorny B, Hirsch E, Cappello P, Martini M. Exploiting pancreatic cancer metabolism: challenges and opportunities. Trends Mol Med. 2024;30:592\u2013604.","journal-title":"Trends Mol Med"},{"key":"3943_CR8","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1080\/15548627.2023.2300913","volume":"20","author":"X Zhang","year":"2024","unstructured":"Zhang X, Lao M, Yang H, Sun K, Dong Y, He L, et al. Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance. Autophagy. 2024;20:1314\u201334.","journal-title":"Autophagy"},{"key":"3943_CR9","first-page":"861","volume":"12","author":"X Chang","year":"2022","unstructured":"Chang X, Liu X, Wang H, Yang X, Gu Y. Glycolysis in the progression of pancreatic cancer. Am J Cancer Res. 2022;12:861\u201372.","journal-title":"Am J Cancer Res"},{"key":"3943_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1586959","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li W, Niu J, Fan Z, Li X, Zhang H. Reprogramming of glucose metabolism in pancreatic cancer: mechanisms, implications, and therapeutic perspectives. Front Immunol. 2025;16:1586959.","journal-title":"Front Immunol"},{"key":"3943_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/iub.2706","volume":"75","author":"M Su","year":"2023","unstructured":"Su M, Shan S, Gao Y, Dai M, Wang H, He C, et al. 2-Deoxy-D-glucose simultaneously targets glycolysis and Wnt\/beta-catenin signaling to inhibit cervical cancer progression. IUBMB Life. 2023;75:609\u201323.","journal-title":"IUBMB Life"},{"key":"3943_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-37483-5","volume":"13","author":"K Miki","year":"2023","unstructured":"Miki K, Yagi M, Noguchi N, Do Y, Otsuji R, Kuga D, et al. Induction of glioblastoma cell ferroptosis using combined treatment with chloramphenicol and 2-deoxy-D-glucose. Sci Rep. 2023;13:10497.","journal-title":"Sci Rep"},{"key":"3943_CR13","doi-asserted-by":"crossref","unstructured":"Huang XM, Huang JJ, Du JJ, Zhang N, Long Z, Yang Y, et al. Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin. Acta Pharmacol Sin. 2021;42:1875\u201387.","DOI":"10.1038\/s41401-021-00612-9"},{"key":"3943_CR14","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1007\/s00432-020-03278-8","volume":"146","author":"AG Simon","year":"2020","unstructured":"Simon AG, Esser LK, Ellinger J, Branchi V, Tolkach Y, Muller S, et al. Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors. J Cancer Res Clin Oncol. 2020;146:2255\u201365.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3943_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.102089","volume":"92","author":"N Ghiglione","year":"2025","unstructured":"Ghiglione N, Abbo D, Bushunova A, Costamagna A, Porporato PE, Martini M. Metabolic plasticity in pancreatic cancer: the mitochondrial connection. Mol Metab. 2025;92:102089.","journal-title":"Mol Metab"},{"key":"3943_CR16","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2014.09.003","volume":"355","author":"D Zhang","year":"2014","unstructured":"Zhang D, Li J, Wang F, Hu J, Wang S, Sun Y. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett. 2014;355:176\u201383.","journal-title":"Cancer Lett"},{"key":"3943_CR17","doi-asserted-by":"crossref","unstructured":"Laussel C, Leon S. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms. Biochem Pharmacol. 2020;182:114213.","DOI":"10.1016\/j.bcp.2020.114213"},{"key":"3943_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/0008-5472.CAN-03-3294","volume":"64","author":"G Maschek","year":"2004","unstructured":"Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, et al. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 2004;64:31\u201334.","journal-title":"Cancer Res"},{"key":"3943_CR19","first-page":"380","volume":"102","author":"KA Kern","year":"1987","unstructured":"Kern KA, Norton JA. Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose. Surgery. 1987;102:380\u20135.","journal-title":"Surgery"},{"key":"3943_CR20","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jcmgh.2020.10.010","volume":"11","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Nishina S, Yamauchi A, Fukuda K, Hara Y, Yamamura M, et al. Nanoparticle-mediated delivery of 2-deoxy-D-glucose induces antitumor immunity and cytotoxicity in liver tumors in mice. Cell Mol Gastroenterol Hepatol. 2021;11:739\u201362.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3943_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217156","volume":"600","author":"Z Kooshan","year":"2024","unstructured":"Kooshan Z, Cardenas-Piedra L, Clements J, Batra J. Glycolysis, the sweet appetite of the tumor microenvironment. Cancer Lett. 2024;600:217156.","journal-title":"Cancer Lett"},{"key":"3943_CR22","doi-asserted-by":"publisher","first-page":"e0130959","DOI":"10.1371\/journal.pone.0130959","volume":"10","author":"SY Wang","year":"2015","unstructured":"Wang SY, Wei YH, Shieh DB, Lin LL, Cheng SP, Wang PW, et al. 2-deoxy-D-glucose can complement doxorubicin and sorafenib to suppress the growth of papillary thyroid carcinoma cells. PLoS One. 2015;10:e0130959.","journal-title":"PLoS One"},{"key":"3943_CR23","doi-asserted-by":"publisher","first-page":"498.","DOI":"10.3390\/cancers15020498","volume":"15","author":"Z Liu","year":"2023","unstructured":"Liu Z, Hayashi H, Matsumura K, Uemura N, Shiraishi Y, Sato H, et al. Biological and clinical impacts of glucose metabolism in pancreatic ductal adenocarcinoma. Cancers (Basel). 2023;15:498.","journal-title":"Cancers (Basel)"},{"key":"3943_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1117-9","volume":"18","author":"X Liu","year":"2019","unstructured":"Liu X, Xu J, Zhang B, Liu J, Liang C, Meng Q, et al. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications. Mol Cancer. 2019;18:184.","journal-title":"Mol Cancer"},{"key":"3943_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"3943_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114633","volume":"43","author":"JH Zheng","year":"2024","unstructured":"Zheng JH, Zhu YH, Yang J, Ji PX, Zhao RK, Duan ZH, et al. A CLIC1 network coordinates matrix stiffness and the Warburg effect to promote tumor growth in pancreatic cancer. Cell Rep. 2024;43:114633.","journal-title":"Cell Rep"},{"key":"3943_CR27","doi-asserted-by":"crossref","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, et al. Increased serotonin signaling contributes to the warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology. 2017;153:277\u2013291.e19.","DOI":"10.1053\/j.gastro.2017.03.008"},{"key":"3943_CR28","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","volume":"167","author":"CS Leonhardt","year":"2024","unstructured":"Leonhardt CS, Gustorff C, Klaiber U, Le Blanc S, Stamm TA, Verbeke CS, et al. Prognostic factors for early recurrence after resection of pancreatic cancer: a systematic review and meta-analysis. Gastroenterology. 2024;167:977\u201392.","journal-title":"Gastroenterology"},{"key":"3943_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.pan.2024.07.017","volume":"24","author":"M Brunner","year":"2024","unstructured":"Brunner M, Flessa M, Jacobsen A, Merkel S, Krautz C, Weber GF, et al. Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - A retrospective analysis of 272 patients. Pancreatology. 2024;24:930\u20137.","journal-title":"Pancreatology"},{"key":"3943_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69:888\u2013900.","journal-title":"Gut"},{"key":"3943_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51232-w","volume":"15","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhang Y, Wang H, Liao L, Ma L, Zhao Y, et al. Hypoxia-induced downregulation of PGK1 crotonylation promotes tumorigenesis by coordinating glycolysis and the TCA cycle. Nat Commun. 2024;15:6915.","journal-title":"Nat Commun"},{"key":"3943_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36651-5","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, He Q, Lu T, Wu J, Shi G, He L, et al. mcPGK1-dependent mitochondrial import of PGK1 promotes metabolic reprogramming and self-renewal of liver TICs. Nat Commun. 2023;14:1121.","journal-title":"Nat Commun"},{"key":"3943_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13601-8","volume":"11","author":"H Nie","year":"2020","unstructured":"Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X, et al. O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020;11:36.","journal-title":"Nat Commun"},{"key":"3943_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3943_CR35","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.gendis.2022.10.006","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Peng Q, Zheng J, Yang Y, Zhang X, Ma A, et al. The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment. Genes Dis. 2023;10:2029\u201337.","journal-title":"Genes Dis"},{"key":"3943_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90.","journal-title":"Mol Cancer"},{"key":"3943_CR37","doi-asserted-by":"crossref","unstructured":"Hou J, Guo M, Li Y, Liao Y. Lactylated histone H3K18 as a potential biomarker for the diagnosis and prediction of the severity of pancreatic cancer. Clinics (Sao Paulo). 2025;80:100544.","DOI":"10.1016\/j.clinsp.2024.100544"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03943-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:03:18Z","timestamp":1790114598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03943-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":37,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2026,10,14]]}},"alternative-id":["3943"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03943-1","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures performed were in accordance with the ethical standards of the Ethical Committee of Guizhou Medical University (approval no. 2020-156; Guiyang, China), the Guizhou Medical University Animal Care Committee (approval no. 2000612), and with The Declaration of Helsinki of 1964 and later versions. All human samples were obtained with the patients\u2019 written informed consent. All institutional and national guidelines for the care and use of laboratory animals were followed.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}